Alex R. Mills, PharmD, BCACP, AAHIVP: No financial relationships to disclose
The study of HIV/AIDS is rapidly evolving. The CDC guidelines concerning the treatment and infection of HIV were last updated in September of 2022. Recommendations concerning monkeypox, co-infection with Hepatitis B or C virus, and C. difficile have been updated. Additional guidance on the treatment of those of childbearing potential, persons who are transgender, those aging with HIV, as well as considerations for patients with substance use disorder are also reviewed. Lastly, new treatment options for HIV prevention are discussed. This cannot miss session reviews changes in guidance affecting community pharmacy practice.
Learning Objectives:
Apply updates to clinical practice guidelines that impact pharmacologic management of HIV.
Summarize first line treatment for HIV in special populations with HIV.
Describe the role of long-acting injectable antiretroviral in the optimization of therapy adherence.
Given a patient case, recommend necessary changes to therapy when a patient has co-infections or other comorbidities alongside their HIV.
Summarize new treatment options in the prevention of HIV.
